Podcasts about Yale school

Sara Raza is the Artistic Director and Chief Curator of the Centre for Contemporary Art (CCA) in Tashkent, Uzbekistan. Of Iranian and Central Asian origin and a member of the international diaspora, Raza focuses on global art and visual cultures from a postcolonial and post-Soviet perspective with a specialism in Orientalism. She is the author of Punk Orientalism: The Art of Rebellion(Black Dog Press, London, 2022). At the helm of the CCA, Raza leads its creative mission to foster cultural and educational partnerships, while championing regional and international artists in their engagement with Uzbekistan's rich cultural heritage and dynamic contemporary art scene. Raza is the recipient of the 11th ArtTable New Leadership Award for Women in the Arts and was honoured by Deutsche Bank and Apollo as one of 40 under 40 global art specialists (thinkers' category). Formerly, she was the Guggenheim UBS MAP Curator for the Middle East and North Africa at the Guggenheim Museum in New York and Curator of Public Programs at Tate Modern in London. She currently teaches in NYU's Media, Cultures, and Communication Department, and is a 2025 Yale School of Art Guest Critic and Visiting Faculty member.She and Zuckerman discuss looking beyond the borders of Europe and the EU, being a global citizen, translation, constellations, mathematics and abstraction, moments of crisis, understanding the present through the past, looking back to look forward, cultures of interruption, finding similarities, punk as a way to combine desperate ideas, reciprocal cultural labor, accessibility, retelling moral tales, art as a re-orientation, and shifting both the imagination and the heart!

Tree plantings have become a go-to climate solution for governments and conservation groups due to the carbon-storing potential of trees.  While planting new trees on open farmland would help capture additional carbon, a new study led by scientists from Yale School of the Environment suggests a powerful alternative: forest-based agroforestry. Instead of clearing land for […]

Aaron Bartz brings a grounded, thoughtful energy to the role of Draco Malfoy in Harry Potter and the Cursed Child, and in this conversation, he shares just how much life and imagination go into keeping the magic alive night after night. From flying and fire to illusions and high-stakes contingencies, Aaron walks us through what it's like to debut on Broadway in one of the most technically demanding plays out there—and why so many actors in the production come from classical Shakespeare backgrounds. We also explore Aaron's journey from Great Falls, Montana to the Lyric Theatre in NYC, including a pivotal classroom moment that set him on the path to acting, and how a love of storytelling (and a little persistence) helped him land gigs that ultimately led to an MFA from Yale. Now a father of two, Aaron reflects on how playing Draco as a parent has shifted his own understanding of growth, vulnerability, and legacy. Aaron Bartz is an actor and writer currently starring as Draco Malfoy in Harry Potter and the Cursed Child on Broadway. He earned his MFA from the Yale School of Drama and began his career with regional Shakespeare productions across the country. He toured nationally with the Montana Repertory Theatre in To Kill a Mockingbird, and his previous work includes Loves Labour's Lost, Macbeth, and other classical works. This episode is brought to you by WelcomeToTimesSquare.com, the billboard where you can be a star for a day. Connect with Aaron: Instagram: @aaronbartz Connect with The Theatre Podcast: Support the podcast on Patreon and watch video versions of the episodes: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon.com/TheTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter & Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@theatre_podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook.com/OfficialTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TheTheatrePodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Alan's personal Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@alanseales⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email me at feedback@thetheatrepodcast.com. I want to know what you think. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of PRIM&R's podcast, "Research Ethics Reimagined," we explore groundbreaking cancer vaccine research for dogs with potential implications for human cancer treatment. Our guest is Dr. Mark Mamula, Professor at the Yale School of Medicine and leading researcher in immunology and innovative vaccine development. 

When it comes to spinal oncology, no single specialty holds all the answers. In this episode of the BackTable Podcast, host Dr. Alexa Levey, an interventional radiologist from Yale School of Medicine, is joined by Dr. Mark Amsbaugh, a radiation oncologist, and Dr. Ran Lador, an orthopedic spine surgeon, both from the University of Texas McGovern Medical School. The discussion explores complexities and innovations in the multidisciplinary treatment of spinal tumors. --- SYNPOSIS Dr. Ambsbaugh and Dr. Lador highlight their cohesive, patient-centered approach at Memorial Hermann, integrating various specialties including surgery, radiation oncology, and interventional radiology. The episode emphasizes the importance of collaborative techniques, advances in minimally invasive surgeries, the role of stereotactic radiosurgery, and the critical nature of personalized patient care in improving outcomes for patients with spinal tumors. --- TIMESTAMPS 00:00 - Introduction01:20 - Multidisciplinary Approach to Spinal Tumors at Memorial Hermann10:22 - Surgical Techniques and Timing for Radiation Treatments 12:25 - Approach to Collaborative Treatment Planning25:45 - Connection Between Surgical and Radiation Oncology in Patient Care31:08 - The Role of Vertebral Augmentation in Spinal Oncology40:08 - Multimodal Pain Management Strategies47:35 - Thoughts on Future Directions in Spinal Oncology and Conclusion --- RESOURCES Dr. Mark Amsbaugh, MDhttps://med.uth.edu/neurosciences/dr-mark-j-amsbaugh-md/ Dr. Ran Lador, MDhttps://med.uth.edu/ortho/2022/11/02/ran-lador-md/ Dr. Alexa Levey, MDhttps://medicine.yale.edu/profile/alexa-levey/

Brennan Brown is a stage and screen actor known for portraying complex and multifaceted characters. After graduating from Yale School of Drama, he landed roles on Broadway in revivals of Shaw's Major Barbara, and Stoppard's The Real Inspector Hound and The Fifteen Minute Hamlet, and in leading theatres throughout America. On screen Brennan has worked with such visionary directors including Tim Hooper on HBO's “John Adams”, John Requa and Glenn Ficarra on both of their films, I Love You Phillip Morris, and Focus, State of Play (dir. Kevin Macdonald), Detachment (dir. Tony Kaye), Midway (dir. Roland Emmerich), The Wolf Hour, and Not Okay. He has appeared in dozens of primetime shows most notably as antique dealer Robert Childan on the acclaimed Amazon series “The Man in the High Castle”, Edward Biben on "Mozart in the Jungle", Agent Donnelly on "Person of Interest", and for the past ten seasons as Dr. Sam Abrams on "Chicago Med". He also appears in the upcoming Netflix series “The Beast In Me”. Other appearances on long running shows including ”Madam Secretary","Elementary","The Blacklist",“Damages",“Bull”, "Ugly Betty","The Good Wife”, "Breaking Bad” and others. We chat about being an introvert, flow state, his medallion on circle cinemas walk of fame, moving around a lot as child, sobriety, auditioning, the Man in the High Castle, Chicago Med, perfectionism and wanting to get it ‘right', unlearning, meditation + plenty more! Check Brennan out on: Instagram: https://www.instagram.com/thebrennanbrown ------------------------------------------- Follow @Funny in Failure on Instagram and Facebook https://www.instagram.com/funnyinfailure/ https://www.facebook.com/funnyinfailure/ and @Michael_Kahan on Insta & Twitter to keep up to date with the latest info. https://www.instagram.com/michael_kahan/ https://twitter.com/Michael_Kahan

At the 2025 Kidney Cancer Research Summit hosted by KidneyCAN, CancerNetwork® spoke with a variety of leading experts about key developments in the research and management of kidney cancer. Throughout the meeting, presenters shared their findings related to updated clinical trial results, personalized cancer vaccines, potential biomarkers of interest, and other advancements in the field. Thomas Powles, MBBS, MCRP, MD, discussed outcomes from a quality-adjusted survival time without symptoms or toxicity (Q-TWiST) analysis of the phase 3 LITESPARK-005 trial (NCT04195750), in which investigators evaluated treatment with belzutifan (Welireg) vs everolimus (Afinitor) among patients with advanced renal cell carcinoma (RCC). Powles, a professor of genitourinary oncology, lead for Solid Tumor Research, and director of Barts Cancer Institute at St. Bartholomew's Hospital, Queen Mary University of London, stated that these data demonstrate how belzutifan is more active and better tolerated than everolimus in this patient population. David A. Braun, MD, PhD, assistant professor at Yale School of Medicine and member of the Center of Molecular and Cellular Oncology within the Yale Cancer Center, detailed his presentation on a personalized neoantigen cancer vaccine as a treatment for those with RCC. Based on his presentation, Braun highlighted how neoantigen vaccines may effectively yield T-cell responses in patients, illustrating a need for additional, larger studies to elucidate the clinical activity of this modality in an adjuvant setting. Additionally, Wenxin (Vincent) Xu, MD, a medical oncologist at Dana-Farber Cancer Institute and an assistant professor of medicine at Harvard Medical School, spoke about his presentation on how kidney injury molecule-1 (KIM-1) may serve as a prognostic biomarker of response to therapy in patients with RCC. His research posed questions on how KIM-1 can inform the use of adjuvant therapy or specific therapeutic combinations like nivolumab (Opdivo) plus ipilimumab (Yervoy) for this patient population. Eric Jonasch, MD, gave an overview of his presentation focused on the Kidney Cancer Research Consortium, a research partnership spanning 7 institutions dedicated to facilitating mechanistic, hypothesis-testing clinical trials in RCC. Jonasch, a professor in the Department of Genitourinary Medical Oncology of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, described how this collaboration aims to link identifiable biological characteristics of RCC subtypes to specific treatment strategies while developing predictive biomarkers. KidneyCAN is a nonprofit organization with a mission to accelerate cures for kidney cancer through education, advocacy, and research funding. You can learn more about KidneyCAN's work here: https://kidneycan.org/ References 1. Powles T, de Velasco G, Choueiri TK, et al. Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of belzutifan versus everolimus in previously treated advanced renal cell carcinoma (RCC): LITESPARK-005 (LS-005). Presented at the 2025 Kidney Cancer Research Summit; July 17-18, 2025; Boston, MA. Abstract 13. 2. Braun DA. Personalized vaccines in kidney cancer: a journey from concept to clinic. Presented at the 2025 Kidney Cancer Research Summit; July 17-18, 2025; Boston, MA. 3. Xu W. From bench to bedside: advancing KIM-1 as a tool for clinical decision-making. Presented at the 2025 Kidney Cancer Research Summit; July 17-18, 2025; Boston, MA. 4. Jonasch E. Building the infrastructure for discovery: a clinical trial consortium to accelerate kidney cancer research. Presented at the 2025 Kidney Cancer Research Summit; July 17-18, 2025; Boston, MA.

Loving-kindness meditation, also called metta,  springs from a basic understanding of human nature: On one hand, we might truly believe that  compassion makes the world better—and on the other, we might struggle to offer it to ourselves and to others for various reasons.  Metta practices, like the one Dr. Emma Seppälä leads this week, offer a simple, structured way to help us  gently expand our capacity to both give and receive love.  As a bestselling author, Yale lecturer, and international keynote speaker, Emma Seppälä teaches executives at the Yale School of Management and is faculty director of the Yale School of Management's Women's Leadership Program. A psychologist and research scientist by training, her expertise is the science of happiness, emotional intelligence, and social connection. Her bestselling book The Happiness Track (HarperOne, 2016) has been translated into dozens of languages. Her new book is Sovereign (Hay House, 2024). Seppälä is also the Science Director of Stanford University's Center for Compassion and Altruism Research and Education. The transcription of this guided meditation will be online at Mindful.org next week.  Stay curious, stay inspired. Join our community by signing up for our free newsletter:  mindful.org/signup Show Notes Find more from Dr. Emma Seppälä here. Go Deeper If you want to understand more about the practice of loving-kindness, why it matters, and how to build it—even with difficult people or in times when you aren't feeling very compassionate—here are some articles to get you started:  Wise Engagement with the World: What to Do When You Wish Things Were Different Loving-Kindness Meditation with Sharon Salzberg For more practice, here's another meditation to try: A 12-Minute Meditation for Self-Compassion and Loving-Kindness. And more from Mindful here: More episodes of 12 Minute Meditation Let us know what you thought of this episode of 12 Minute Meditation by leaving a review or by emailing yourwords@mindful.org.

Howie and Harlan are joined by public health communicator Katelyn Jetelina for updates on COVID-19 and other issues, and to discuss how her emails to students and colleagues in the early days of the pandemic turned into a platform with global reach. Harlan looks at how AI is being used on both sides of the battle between providers and insurers over claims; Howie reports on a setback with a promising gene therapy for Duchenne muscular dystrophy. Links: Insurance Claims, AI, and Wearables “Elevance Health Reports Second Quarter 2025 Results” “Elevance lowers profit outlook, warns things will get worse for health insurers ““Blue KC wrongfully denied medical diagnoses, hospital alleges in AI-driven claims lawsuit” “Oscar Health cuts full-year guidance, estimates 2025 loss as ACA marketplace stumbles” Whoop “WHOOP Delivers Innovative Blood Pressure Insights for a Deeper Look at Your Well-Being” “Introducing Heart Screener: A smarter way to stay connected to your heart health” “Whoop says FDA is ‘overstepping its authority' with warning about blood pressure feature” FDA: WARNING LETTER, WHOOP, Inc. “RFK Jr. wants everyone to use wearables. What are the benefits, risks?” “Apple to Sell Watches With Blood-Oxygen Feature Disabled After Legal Setback” Your Local Epidemiologist Your Local Epidemiologist “Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism” “Popular epidemiologist lays out future path of public health communication” Yale School of Public Health: PopHIVE Katelyn Jetelina: “NIH: The quiet engine of science is being dismantled” Katelyn Jetelina: “Covid-19 in pockets, sugar cane isn't better, ticks march on, rescission cuts (vs. everything else), bright spots, and more” Mayo Clinic: Norovirus infection Katelyn Jetelina: “The show must go on...” Katelyn Jetelina: “Harassment against scientists is out of control” Katelyn Jetelina: “Medicaid cuts: The how and why” CDC: H5 Bird Flu: Current Situatio CDC: Current Epidemic Trends (Based on Rt) for States” CDC: Measles Cases and Outbreaks Treating Duchenne Muscular Dystrophy Cleveland Clinic: Duchenne Muscular Dystrophy (DMD) “FDA approves Sarepta's Duchenne gene therapy for nearly all patients” “AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial” “Patient dies in Sarepta gene therapy trial, adding to safety concerns” “FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths” “In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy” “Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

rWotD Episode 3003: C. Stanley Lewis Welcome to random Wiki of the Day, your journey through Wikipedia's vast and varied content, one random article at a time.The random article for Thursday, 24 July 2025, is C. Stanley Lewis.C. Stanley Lewis, or Stanley Lewis (born 1941) is an artist and art teacher. He was a member of the Bowery Gallery in New York City from 1986 to 2008 and of the Oxbow Gallery in Northampton, Massachusetts. Lewis is currently represented by the Betty Cuningham Gallery in New York City.An emeritus professor from American University, Lewis also taught at the Kansas City Art Institute from 1969 to 1986, and currently teaches part-time at the New York Studio School. In addition, Lewis has taught at Kansas City Art Institute, Smith College, and the Parsons School of Design. In 2001, he was Artist-in-Residence at Dartmouth College. "Recent group exhibitions in 2009 include the American Academy of Arts & Letters Invitational; Haverford College and Gross-McCleaf Gallery, PA." Lewis has been the recipient of many awards, including the Altman Prize, a Henry Ward Ranger Purchase Award from the National Academy of Design, and a Guggenheim Fellowship in 2005. He was also a Danforth Fellow.There was a major retrospective of Lewis' work at the American University Museum in the Katzen Arts Center in Washington, D. C. in 2007. He is a graduate of Wesleyan University and received both a BFA and an MFA from the Yale School of Art.In a 2011 review in The Brooklyn Rail of Lewis's recent work, Ben La Rocco writes, "Lewis's paintings are questions. How can paint address the quality of light and presence of a place so as to rival the experience of the place itself?"This recording reflects the Wikipedia text as of 01:19 UTC on Thursday, 24 July 2025.For the full current version of the article, see C. Stanley Lewis on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm neural Jasmine.

Dans sa course à la suprématie énergétique, Pékin met les bouchées doubles. Annoncé le 21 juillet par le Premier ministre chinois Li Qiang et relayé par Reuters, un chantier titanesque vient de démarrer au cœur de l'Himalaya, dans la région autonome du Tibet. Il s'agit d'un barrage colossal, bâti sur le fleuve Yarlung Tsangpo — aussi appelé Brahmapoutre. L'objectif ? Produire l'équivalent de la consommation énergétique annuelle du Royaume-Uni. Rien que ça.Le projet impressionne par ses chiffres : 20 milliards d'euros d'investissement, 300 milliards de kilowattheures prévus chaque année, et une implantation dans un tronçon du fleuve où l'eau chute de 2 000 mètres sur seulement 50 kilomètres. Le potentiel hydroélectrique est immense… mais les tensions aussi. Car ce barrage suscite de vives inquiétudes, notamment du côté de l'Inde et du Bangladesh. En aval du fleuve, on redoute une gestion autoritaire du débit par Pékin, avec à la clé une pression diplomatique, voire une arme stratégique déguisée. L'Australian Strategic Policy Institute alerte même sur le risque de « retenues coercitives » en cas de conflit, ou pire, de crues contrôlées visant le territoire indien.Sur le plan écologique, plusieurs ONG, ainsi que la Yale School of the Environment, tirent la sonnette d'alarme. Le projet pourrait bouleverser des écosystèmes rares, submerger des forêts centenaires, dérégler la faune locale, et accentuer l'érosion jusqu'au delta du Bengale. Rappelons que le Tsangpo est l'un des canyons les plus profonds et les plus méconnus de la planète, abritant plus de 4 000 espèces végétales recensées par des chercheurs chinois. Malgré ces alertes, la Chine avance. Le chantier du siècle est lancé. Mise en service prévue dans les années 2030. Quant aux conséquences environnementales et géopolitiques, elles, pourraient bien se faire sentir beaucoup plus tôt. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Howie and Harlan are joined by public health communicator Katelyn Jetelina for updates on COVID-19 and other issues, and to discuss how her emails to students and colleagues in the early days of the pandemic turned into a platform with global reach. Harlan looks at how AI is being used on both sides of the battle between providers and insurers over claims; Howie reports on a setback with a promising gene therapy for Duchenne muscular dystrophy. Links: Insurance Claims, AI, and Wearables “Elevance Health Reports Second Quarter 2025 Results” “Elevance lowers profit outlook, warns things will get worse for health insurers ““Blue KC wrongfully denied medical diagnoses, hospital alleges in AI-driven claims lawsuit” “Oscar Health cuts full-year guidance, estimates 2025 loss as ACA marketplace stumbles” Whoop “WHOOP Delivers Innovative Blood Pressure Insights for a Deeper Look at Your Well-Being” “Introducing Heart Screener: A smarter way to stay connected to your heart health” “Whoop says FDA is ‘overstepping its authority' with warning about blood pressure feature” FDA: WARNING LETTER, WHOOP, Inc. “RFK Jr. wants everyone to use wearables. What are the benefits, risks?” “Apple to Sell Watches With Blood-Oxygen Feature Disabled After Legal Setback” Your Local Epidemiologist Your Local Epidemiologist “Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism” “Popular epidemiologist lays out future path of public health communication” Yale School of Public Health: PopHIVE Katelyn Jetelina: “NIH: The quiet engine of science is being dismantled” Katelyn Jetelina: “Covid-19 in pockets, sugar cane isn't better, ticks march on, rescission cuts (vs. everything else), bright spots, and more” Mayo Clinic: Norovirus infection Katelyn Jetelina: “The show must go on...” Katelyn Jetelina: “Harassment against scientists is out of control” Katelyn Jetelina: “Medicaid cuts: The how and why” CDC: H5 Bird Flu: Current Situatio CDC: Current Epidemic Trends (Based on Rt) for States” CDC: Measles Cases and Outbreaks Treating Duchenne Muscular Dystrophy Cleveland Clinic: Duchenne Muscular Dystrophy (DMD) “FDA approves Sarepta's Duchenne gene therapy for nearly all patients” “AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial” “Patient dies in Sarepta gene therapy trial, adding to safety concerns” “FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths” “In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy” “Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

For episode 268, Emma Seppälä returns to the Metta Hour for our ongoing Anxiety Series.In this series, Sharon is speaking with Mental Health experts, providers and different researchers for tools to work with anxiety in increasingly challenging times. This is the eighth episode in the series.Emma Seppälä is a best-selling author, Yale lecturer, and international keynote speaker. She teaches executives at the Yale School of Management and is faculty director of the Yale School of Management's Women's Leadership Program. She is also the Science Director of Stanford University's Center for Compassion and Altruism Research and Education. A psychologist and research scientist by training, Emma's expertise is the science of happiness, emotional intelligence, and social connection. Her latest book, “Sovereign: Reclaim Your Freedom, Energy, and Power in a Time of Distraction, Uncertainty, and Chaos” came out in 2024.In this conversation, Emma and Sharon speak about:Mental Health study on university studentsHow self-compassion figures into wellbeingReflective Best-Self Exercise How the Dalai Lama made a mistakeSovereignty: awareness + courage + energySuppressing emotions makes them strongerEmma's experience with an Eating DisorderWorking with difficult emotionsDifferent regulation techniquesBreathing techniques for regulationResearch on LovingkindnessBenefits of meditationHow intuition can help our anxietyEmma closes the conversation with a guided breathing practice. To learn more about Emma's work and get a copy of “Sovereign” on her website right here. Learn about Emma's 6-week course, the Science of Sovereignty right here.Check out the first episode in the Anxiety Podcast Series with Dr. Jud Brewer on Ep.260 of the Metta Hour Podcast.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

James Kimmel, Jr., JD, is a violence researcher, psychiatry professor, and author who explores the science of revenge, addiction, forgiveness, and violence. He is the author of three books on revenge, his most recent is, The Science of Revenge: Understanding the World's Deadliest Addiction–and How to Overcome It. In this conversation, James shares the research he has conducted and explains how he first identified compulsive revenge seeking as an addiction. He made the study of revenge and forgiveness his life's work after nearly committing a mass shooting as a teenager which you'll hear about in the interview. James is an Assistant Clinical Professor of Psychiatry at the Yale School of Medicine and the founder and co-director of the Yale Collaborative for Motive Control Studies. Be sure to share this conversation with a friend. RESOURCES MENTIONED JOIN MICHELE'S NEWSLETTER + Receive A Free Curated List of 52 Self-care Tips Michele's Book: Design a Life You Love GUEST INFORMATION Website: https://www.jameskimmeljr.com and https://www.miraclecourt.com Book: The Science of Revenge: Understanding the World's Deadliest Addiction–and How to Overcome It This conversation is for educational and entertainment purposes only. It does NOT constitute medical, mental health, legal, business, or other advice. Consult a qualified and trusted professional. If you enjoyed this interview, please take a moment to rate and review it on Apple Podcasts. Your reviews are so appreciated! XO, Michele

Today, on Notable Leaders' Radio, I speak with Kijuan Amey, Chief Motivation Officer of Amey Motivation LLC. He highlights his extraordinary journey living his dream of working in the Air Force to an accident that changed him forever. He shares how redefining his life through resilience, faith, and the power of vulnerability, gave him what he needed to thrive again.   In today's episode, we discuss: Reframe vulnerability as a source of strength. Embrace open self-expression and honesty about your struggles. This can foster healing, help you confront past pain, and empower both yourself and others. Acknowledge and address mental health openly. Recognize the reality of emotional struggles, such as depression after trauma. Seeking support and being transparent about difficulties can reduce stigma and provide relief. Remind yourself that setbacks do not define you. Internalize the mantra, “my situation does not define who I am.” Use this belief to separate your identity from your circumstances and maintain hope for your future. Appreciate the hidden lessons in adversity. Understand that challenges during childhood or unexpected setbacks build resilience and self-reliance. Apply this mindset to reframe today's difficulties as opportunities for growth. RESOURCES: Guest Bio From serving in the US Air Force to becoming a CEO, mentor, and bestselling author, Kijuan's journey has been nothing short of remarkable. Born and raised in Durham, NC, he's a true testament to the power of determination and perseverance.  - Serving 10 years in the Air Force, advancing to the rank of Staff Sergeant.  - Former Vice President for the Carolina regional group of the Blinded Veterans Association.  - Mentor and ambassador for the Air Force Wounded Warriors program.  - A talented drummer with 25+ years of experience.  -On-stage actor. - Author of the bestseller, "Don't Focus on Why Me."  In a life-altering moment on May 5th, 2017, he lost his eyesight in a motorcycle accident. But as Kijuan says, "I may have lost my sight, but I did not lose my vision."  Now, Kijuan is a motivating force, empowering others to overcome odds and achieve success. No matter the audience or location, he's ready for the task, from captivating crowds of 1,500 to one-on-one sessions, he is now the chief motivational officer of Amey Motivation LLC.   Website/Social Links: ♦      LinkedIn:  https://www.linkedin.com/in/kijuan-amey-783889121?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app   ♦      Instagram:     https://www.instagram.com/kijuanamey?igsh=NmZtNHRqbW1meWNy&utm_source=qr   ♦      Facebook:     https://www.facebook.com/share/1Bq7zzDeV5/?mibextid=wwXIfr   Belinda's Bio: Belinda Pruyne is a renowned Leadership Advisor, Executive Coach, Consultant, and Keynote Speaker recognized for her ability to transform executives, professionals, and small business owners into highly respected, influential leaders. As the Founder of BelindaPruyne.com, she partners with top-tier organizations, including IBM, Booz Allen Hamilton, BBDO, Hilton, Leidos, Yale School of Medicine, Landis, Discovery Channel, and the Portland Trail Blazers. Recently, she led the redesign of two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is also a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. A thought leader in leadership development, Belinda is the creator and host of the Notable Leaders Radio podcast, where she has conducted 95+ interviews with top executives and business leaders, revealing the untold stories behind their success. Previously, as Executive Vice President, Global Director of Creative Management at Grey Advertising, she oversaw a global team of 500 professionals, gaining deep expertise in client services and executive leadership. With 25+ years of experience, Belinda is a trusted advisor to startups, turnarounds, acquisitions, and Fortune 500 companies, delivering strategic, high-impact solutions in today's fast-evolving business landscape. Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

Andrew is the Janet Yellen Professor of Finance and Management at the Yale School of Management and Director of the Yale Program on Financial Stability, specializing in financial crises. He discusses the vulnerabilities of the banking system, lessons from recent crises like SVB and the GFC, the government's role in crisis management, and the biggest risks facing today's financial system.

In this episode, I sit down with Zenobia Morrill, Ph.D., who shares her journey into psychotherapy—from a personal confrontation with existential truth to navigating her family's intergenerational pain. Dr. Morrill reflects on her early experiences as a therapy client, where she encountered traditional frameworks that often fell short, approaches that pathologized pain while ignoring the broader systemic and historical forces at play. Grounded in liberation psychology and critical theory, Dr. Morrill offers a compelling critique of mainstream psychological models that individualize suffering and overlook the impact of power, politics, and culture. We explore how psychotherapy can become a tool for liberation, not by reinforcing institutional norms, but by creating space to challenge and reimagine them in service of opening up possibilities for personhood. Dr. Morrill shares how critical-liberation psychotherapy offers practitioners a framework to question how therapeutic practices may either reinforce alienation or open new paths toward freedom, healing, and fuller participation in society. She reflects on the importance of broadening our range of being, reclaiming repressed parts of the self, and bridging individual pain to collective emancipation. Therapy, she argues, must move beyond static formulations and recognize that social, political, and cultural forces are already present in the room—they are not “add-ons” but essential to the client's lived experience. This approach does not suggest liberation occurs solely within the therapy room, but asks how the institution of therapy itself—its theories, method, and practices—can be used to support liberatory outcomes. Ultimately, Dr. Morrill calls on therapists to resist objectification of clients and of therapy itself—and to reimagine psychotherapy as a dynamic, relational, and contextually grounded space for transformation. Zenobia Morrill, Ph.D., is a critical-liberation psychologist and psychology professor at William James College. She received her doctorate from the University of Massachusetts Boston and completed her pre- and post-doctoral fellowship at the Yale School of Medicine and at Yale Health, Mental Health & Counseling, respectively. Inspired by her personal and professional experiences with the mental health system, Dr. Morrill emphasizes the power in psychological frameworks as the stories we use to understand ourselves, and the risks presented when these frameworks cannot capture the complex existential, sociocultural, familial, physiological, and tacit dimensions of humanity. Her work centers on the belief that psychological healing must account for these broader meaning systems and political structures that shape individual experience. Her research and clinical interests include psychotherapy process, global mental health, qualitative methodology, theory and philosophy, and critical and liberation psychologies. A recipient of the American Psychological Association's Sigmund Koch Award for Early Career Contribution to Psychology, Dr. Morrill's work and Critical-Liberation Psychotherapy model have been recognized and presented internationally.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sernova has a new partner and a new drug for cell transplants, at home glucose/T1D test research, study looks at best diet for people with type 2, Lifescan files for banktrupcy, T1D Barbie and more! Find out more about Moms' Night Out  Read Hangy Woman's take on Barbie (and send me yours!)  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: In the News July 18   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Sernova is partnering with Eledon Pharmaceuticals to test a new immunosuppressive drug in its ongoing clinical trial for people with type 1 diabetes (T1D). The drug called tegoprubart is designed to protect transplanted islet cells without harsh side effects. The current treatment is known for its potential toxicity, especially towards insulin-producing beta cells, and its adverse side effects, making it less than ideal for islet cell therapy in T1D. Tegoprubart has already shown promise in earlier trials, helping T1D patients achieve insulin independence with better graft survival and fewer side effects. This next phase of Sernova's trial (Cohort C) will combine Eledon's drug with Sernova's Cell Pouch, an implantable device that houses insulin-producing cells. In earlier phases, six participants stopped needing insulin completely, with results lasting years. Sernova also plans to use stem cell-derived islet-like clusters from partner Evotec to create a next-gen therapy. If all goes well, a new clinical program could launch in 2026.   https://www.streetwisereports.com/article/2025/07/15/biotech-partnership-to-revolutionize-diabetes-treatment.html XX Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1 diabetes (T1D) in individuals with T1D autoantibodies. Developed by Digostics (Dih-jos-tiks), the test offers a simpler, less invasive alternative to clinic-based oral glucose tolerance tests. The study aims to assess its accuracy, usability, and acceptance, potentially paving the way for wider use in early T1D detection and monitoring. The results of the trial will inform future regulatory submissions for GTT@home use in T1D, which already has regulatory approval in the UK, Europe and other regions for other types of diabetes. https://finance.yahoo.com/news/digostics-announces-university-trial-home-164300142.html XX LifeScan announced that it entered into a restructuring support agreement and, to implement it, filed for chapter 11 bankruptcy. As the process moves forward, LifeScan plans to operate in the ordinary course of business. It expects to emerge from chapter 11 by the end of the year. LifeScan develops the OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app that provide simplicity, accuracy and trust in diabetes management. XX New study looks at quality of life and cost of AID systems. This was done in Finland which has the highest prevalence of T1D in the world. The results show automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications. The quality-adjusted life expectancy increased by an average of 2.3 years for individuals using an automated insulin delivery pump. Although the overall costs of automated insulin delivery pump treatment were higher than those of conventional insulin pump treatment, its cost-effectiveness ratio was well below the generally accepted willingness-to-pay threshold of 50,000 euros in Finland. This is the first cost-effectiveness study of automated insulin delivery pumps conducted in Finland. https://medicalxpress.com/news/2025-07-automated-insulin-delivery-effective-treatment.html XX Blue Circle Health expands into the 11th state: Louisiana! This is Free, comprehensive virtual clinical care, education, and support program for adults with type 1 diabetes In addition to serving adults with type 1 diabetes in Louisiana, our program is also active in Alabama, Mississippi, Florida, Missouri, Iowa, Ohio, Vermont, New Hampshire, Maine, and Delaware.  The program serves as an extension of participants' existing care teams and ensures continuity of care The organization hopes to inform new care models and policies that remove barriers to healthcare People with T1D over 18 years of age who speak English or Spanish are eligible to enroll. To sign up directly, refer a person living with T1D, or learn how you can partner with Blue Circle Health, visit www.bluecirclehealth.org. XX A new study comparing three popular diets—intermittent fasting, time-restricted eating, and continuous calorie cutting—found that all can help people with type 2 diabetes lose weight and lower blood sugar. But one diet stood out: the 5:2 intermittent fasting plan, where participants eat normally five days a week and restrict calories on two. It led to better results in fasting blood sugar, insulin response, and sticking with the plan. Although researchers identified improved HbA1c levels, and adverse events were similar across the three groups, the IER group showed greater advantages in reducing fasting blood glucose, improving insulin sensitivity, lowering triglycerides, and strengthening adherence to the dietary interventions. https://www.sciencedaily.com/releases/2025/07/250715043351.htm XX MIT students have developed an implantable device.. for use during emergency low blood sugars.   The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.   The researchers showed that this device could also be used to deliver emergency doses of epinephrine, a drug that is used to treat heart attacks and can also prevent severe allergic reactions, including anaphylactic shock. The device contains a powdered form of glucagon and can be remotely triggered—either manually or automatically by a glucose monitor—to release the hormone when blood sugar drops too low. No word on next steps to make this commercially available.   https://news.mit.edu/2025/implantable-device-could-save-diabetes-patients-low-blood-sugar-0709 XX We've covered T1D1 before, this is an insulin calculator app – there's more to it than that.. it was created by 13 year old Drew who lives with type 1, but removed from the apps stores a few years ago, along with other non fda cleared apps. Drew who is now 18, Tells us they just submitted to the FDA and are optimistic about being reinstated. https://www.instagram.com/t1d1app/ XX   XX 1'm Brodie Sargent, a Type 1 diabetic raised in Mudgee, NSW, and currently living in Wollongong.   Starting August 26th, I'll be running a marathon every day for 26 days, and on the 27th day, I'll be finishing with Western Sydney's Half Ironman.   The current world record for the most consecutive marathons run by a Type 1 diabetic male is 25 and I'm aiming to break it.   I'm doing this to inspire others, diabetic or not, to challenge themselves and not let anything hold them back.   Any donation is greatly appreciated and supports a cause I truly believe in. The Type One Foundation focuses on support, connection, awareness, and advocacy for diabetics across Australia. They run online and in-person events for diabetics and their families, and also offer care packages to those newly diagnosed.   I was diagnosed at 15, and it was a tough time for me and my family, we had no history or understanding of diabetes. I was already a shy and awkward kid, and I struggled to speak up about how much it affected me. I started running with my roommate just to kill time but it quickly took over my life. Feeling stuck and unsure where I was heading, I decided to make a change and try to help anyone out there feeling the same way.   You can follow my journey on Instagram: @typerun_   XX Launched during children's congress To further promote inclusivity and tackle the stigma associated with the condition, Mattel partnered with Breakthrough T1D, a global organization dedicated to type 1 diabetes research and advocacy, to launch its first Barbie with type 1 diabetes. This partnership marks a major milestone in Mattel's commitment to greater representation, and highlights Breakthrough T1D's pivotal role in ensuring visibility for the type 1 diabetes community.   The doll is part of the Barbie Fashionistas line and includes key diabetes management tools modeled accurately with the help of Breakthrough T1D. The type 1 diabetes Barbie wears a continuous glucose monitor (CGM) secured with Barbie-pink, heart-shaped tape, and has an insulin pump at her waist. She also comes with a CGM-tracking smartphone, a pastel blue purse, and a blue polka dot outfit – blue being the color that symbolizes global diabetes awareness.   As part of a broader initiative to elevate voices in the type 1 diabetes community, Barbie also partnered with two global role models living with type 1 diabetes: Peloton Instructor Robin Arzón and model Lila Moss.   Robin Arzon Barbie Image Credit: Breakthrough T1D and Mattel Mattel's one-of-a-kind doll based on Arzón features her signature yellow outfit and a crown-shaped CGM on the back of her arm.   In interviews, Moss has highlighted the positive impact that the type 1 diabetes Barbie's visibility has already had, saying she receives daily messages from young people who feel less insecure about wearing their diabetes devices thanks to her public advocacy.   When Linxi Mytkolli, director of patient engagement at Diabetes Action Canada and person with diabetes, heard about the new “Dia Barbie,” she said she teared up.   “I grew up loving dolls, but I never saw one that reflected the reality I now live with – until Dia Barbie. Seeing a doll with a CGM, insulin pump, and even heart-shaped medical tape felt surreal. It's playful, powerful, and personal all at once,” said Mytkolli.   Mytkolli also emphasized that representation and visibility in toys and media can help chip away at shame.   “I've heard from so many people, especially those diagnosed in childhood, who delayed using tech like pumps or CGM because it felt like a punishment. Visibility in toys helps normalize these devices and makes kids feel like they're not alone or ‘othered.' It turns stigma into something softer – something that can be talked about, shared, even celebrated,” Mytkolli said.   And its impact goes beyond people living with diabetes. Laura Pavlakovich, who is the founder and CEO of You're Just My Type and has lived with type 1 diabetes since age five, shared that this representation is equally crucial for those without diabetes, as it demystifies the condition and challenges stereotypes.   “This kind of representation builds a vital bridge of empathy, illustrating that living with diabetes is simply a part of life for millions. It's an essential tool for educating the public and cultivating a more inclusive and supportive society for everyone,” said Pavlakovich.   Pavlakovich shared her personal experience of growing up with diabetes and how this will provide validation for those with the condition who often feel unseen.   “I vividly remember growing up with a 'my twin' doll, custom-made to look just like me, yet she always lacked the crucial part of my daily reality: an insulin pump. To finally see a Barbie, an iconic figure in childhood play, accurately depict someone living with type 1 diabetes, complete with her devices and pump, is truly a monumental moment,” said Pavlakovich.   To celebrate the launch, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress in Washington, D.C., where 170 young advocates for type 1 diabetes from around the world met with lawmakers to raise awareness. Priced at $10.99, the doll is now available on Mattel Shop and at retailers nationwide.   While this is a huge win for enhancing the representation of children living with diabetes, it doesn't end there. There is still significant work to be done to improve access to diabetes medication and technology.   “It is not lost on me that Barbie has more access to diabetes tech than many, if not most, people with diabetes globally,” said Mytkolli. “Representation and access – we deserve both.”   By bringing a common but misunderstood condition into children's toy boxes, the new type 1 diabetes Barbie is more than a toy. It's a symbol of pride, visibility, and the message that children with diabetes can live full, empowered lives.   As Mytkolli said, “Whether a child is living with diabetes, or loves someone who is, this doll quietly says, ‘You're not broken. You belong.'”

Foreign aid accounts for 1% of the U.S. federal budget. These funds are used to fight famine and disease worldwide. This week, the Senate will debate cutting $7.9 billion earmarked for these efforts. In July, the Humanitarian Research Lab at Yale had federal funds rescinded. They are currently operating by with the help of individual donors. Today, we get an update on humanitarian crises and international conflicts around the globe. We'll also discuss the future of humanitarian aid in the United States and abroad. GUESTS: Lila Hassan: Independent Investigative Journalist Nathaniel Raymond: Executive Director of the Humanitarian Research Lab at the Yale School of Public Health Provash Budden: Deputy Senior Vice President of Emergency Programs at Americares Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

In this episode of Notable Leaders' Radio, I sit down with Andy Crocker, author of The Unconditionals, to explore how five core values, unconditional love, gratitude, integrity, accountability, and endeavor, can transform how we face challenges and build resilience. Andy shares powerful insights and real-life stories that reveal how grounding yourself in these values can help you recover from failure faster, pivot with purpose, and live a life defined by meaning, not perfection. In this episode, you'll learn how to: See failure as a launchpad, not a dead end. When you stop viewing setbacks as defeat, you recover faster and grow wiser, equipped to seize new opportunities with greater clarity and courage. Define success on your own terms. Ditch the societal checklist. Pursuing fulfillment, not perfection, leads to greater joy, authenticity, and personal achievement. Pivot with purpose when life shifts. Unexpected turns are inevitable. A values-based mindset empowers you to adjust course with intention and rediscover meaning, even in the midst of change. Embrace imperfection as a path to progress. Mastery isn't about getting it right the first time—it's about learning, evolving, and moving forward without fear of failure. RESOURCES: Guest Bio: Andy Crocker is an aerospace executive with three decades of experience building high-performance teams and leading ambitious projects, including NASA's Human Landing System. He holds degrees in engineering, humanities, management, and leadership and is an Associate Fellow of the American Institute of Aeronautics and Astronautics. This multidisciplinary educational background and diverse career shaped his perspective that led him to write The Unconditionals, in which he reveals the foundational, timeless values that help us unlock the potential for our greatest personal and professional fulfillment. He recently founded Overview Affection, a company that aims to extend the values contained in The Unconditionals to individuals and organizations.   Website/Social Links https://andycrockerbooks.com/ https://www.linkedin.com/in/andycrocker/ https://www.facebook.com/andycrockerbooks/  https://www.instagram.com/andycrockerbooks/  BOOKS: The Unconditionals: Five Timeless Values to Live Without Limits and Ignite Your Superpower https://amzn.to/44AptaE   Belinda's Bio: Belinda Pruyne is a renowned Leadership Advisor, Executive Coach, Consultant, and Keynote Speaker recognized for her ability to transform executives, professionals, and small business owners into highly respected, influential leaders. As the Founder of BelindaPruyne.com, she partners with top-tier organizations, including IBM, Booz Allen Hamilton, BBDO, Hilton, Leidos, Yale School of Medicine, Landis, Discovery Channel, and the Portland Trail Blazers. Recently, she led the redesign of two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is also a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. A thought leader in leadership development, Belinda is the creator and host of the Notable Leaders Radio podcast, where she has conducted 95+ interviews with top executives and business leaders, revealing the untold stories behind their success. Previously, as Executive Vice President, Global Director of Creative Management at Grey Advertising, she oversaw a global team of 500 professionals, gaining deep expertise in client services and executive leadership. With 25+ years of experience, Belinda is a trusted advisor to startups, turnarounds, acquisitions, and Fortune 500 companies, delivering strategic, high-impact solutions in today's fast-evolving business landscape. Website: Belindapruyne.com The Values Catalyst: https://belindapruyne.com/vci Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

Maggie Nilz, Senior Analyst of Preparedness at ASTHO, explains how states can help support public health preparedness workforce resilience and capacity; Carolyn Mullen, Senior Vice President for Government Affairs and Public Relations at ASTHO, shares what Congress has been busy with in this week's View from Washington, D.C. report; a new ASTHO resource helps prevent adverse childhood experiences by providing various economic support program options; and Dr. Anne Zink, ASTHO Past President, was named co-leader of a new population health data initiative at the Yale School of Public Health.  ASTHO Health Policy Update: States Stay Prepared by Supporting the Public Health Workforce ASTHO Legislative Alert: One Big Beautiful Bill Law Summary ASTHO Web Page: Prioritizing Economic Support Policies to Prevent ACEs and Promote Public Health Yale School of Public Health unveils PopHIVE  

In America, body weight has become a pain point shrouded in self-recrimination and shame, not to mention bias from the medical community. For many, this battle not only takes a mental toll but also becomes a physical threat: three-quarters of American adults struggle with weight-related health conditions, including high blood pressure, heart disease and diabetes. We know that diets don't work, and yet we also know that excess weight starves us of years and quality of life. Where do we go from here? This evening, Dr. David Kessler will discuss some key points from his new book, Diet, Drugs and Dopamine, which unpacks the mystery of weight in the most comprehensive work to date on this topic, giving readers the power to dramatically improve their health. About the Speakers Dr. David Kessler is a prominent figure in public health, medicine and academia. He served as the commissioner of the FDA from 1990 to 1997, making significant contributions to drug approval, food safety and consumer protection. He is also a professor of pediatrics and epidemiology at the University of California, San Francisco. Additionally, he has served as dean of the Yale School of Medicine and the UCSF School of Medicine. The moderator is Anahad O'Connor. He is a health columnist who writes about food and nutrition for The Washington Post's Well+Being desk. Anahad joined the Post in 2022; before that, he was a staff reporter for The New York Times, where he spent two decades covering health and science. A Nutrition, Food & Wellness Member-led Forum program. Forums at the Club are organized and run by volunteer programmers who are members of The Commonwealth Club, and they cover a diverse range of topics. ORGANIZER: Patty James Learn more about your ad choices. Visit megaphone.fm/adchoices

Howie and Harlan are joined by Azita Emami, dean of the Yale School of Nursing, to discuss the school's approach to training nurses who can have a seat at the table of healthcare decision-making. Harlan reports on his new study showing the low levels of evidence required for medical devices in the FDA's Breakthrough Devices Program; Howie provides some good news about infectious diseases including malaria and HIV. Links: Breakthrough devices? Harlan Krumholz: “FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program” FDA: Breakthrough Devices Program “Many medical devices deemed ‘breakthrough' by FDA are backed by patchy evidence” FDA Facts: Biomarkers and Surrogate Endpoints Harlan Krumholz: “Class I Recalls of Cardiovascular Devices Between 2013 and 2022 : A Cross-Sectional Analysis” Azita Emami “Americans' Ratings of U.S. Professions Stay Historically Low” “University of Washington selects Azita Emami as dean of School of Nursing” “Azita Emami named new dean of School of Nursing” “The Report of the Rockefeller Foundation on Nursing Education: A Review and Critique” Cleveland Clinic: DHEAS Test “DHEA as a Biomarker of Stress: A Systematic Review and Meta-Analysis” Azita Emami: “Assessing stress using repeated saliva concentration of steroid hormones in dementia care dyads: results from a controlled pilot care music intervention” Azita Emami: “The Feasibility and Acceptability of In-Home Saliva Collection for Stress in Persons With Dementia and Their Family Caregivers” Infectious diseases Mayo Clinic: Malaria WHO: World Malaria Report 2024 “Georgia certified malaria-free by WHO” “Suriname certified malaria-free by WHO” The Global Fund to Fight AIDS, Tuberculosis and Malaria “Novartis wins approval for first malaria drug for newborns and babies” “FDA Approves a Twice-Yearly Shot to Prevent HIV” “U.S. measles cases hit highest level in 33 years, CDC reports” Texas Department of State Health Services: Measles Outbreak “The West Texas measles outbreak has started to slow for the first time since January” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Whether you're just beginning to explore the MBA path or are deep into your application journey, this panel from the 2025 Clear Admit MBA Fair is designed to break down the essentials of business school and answer the questions every prospective student has—but might be too afraid to ask. Representatives on this panel include Melissa Rapp, Associate Dean, Graduate Admissions, at Emory Goizueta; Dawna Levenson, Assistant Dean, Admissions at MIT Sloan; Alex Lawrence, Assistant Dean of MBA Admissions and Financial Aid at UCLA Anderson; and Amber Walsh, Senior Associate Director of Yale School of Management. Who actually goes to business school? Do you need a business background to be competitive? What will you study—and how will you learn it? From core curriculum and teaching methods to timing your application and choosing the right program, we'll demystify every step of the process.

Day 1,231.Today, we report on the sudden death of Russia's former transport minister within hours of his sacking by Vladimir Putin. Then we examine Donald Trump's pledge to resume weapons deliveries to Ukraine and look ahead to President Macron's visit to the UK. Finally, we hear an updated figure of the number of children kidnapped by Russia, and discuss their fate if the Yale Humanitarian Research Lab closes this autumn amid its funding being pulled.Contributors:Adélie Pojzman-Pontay (Journalist and Producer). @adeliepjz on X.Dominic Nicholls (Associate Editor of Defence). @DomNicholls on X.Francis Dearnley (Executive Editor for Audio). @FrancisDearnley on X.Nathaniel Raymond (Lecturer & Executive Director Humanitarian Research Lab at Yale School of Public Health) @nattyray11 on X.Content Referenced:‘Help the Humanitarian Research Lab Keep Finding Ukraine's Abducted Children ':https://medicine.yale.edu/lab/khoshnood/give-now/Fired Russian minister ‘kills himself' (The Telegraph):https://www.telegraph.co.uk/world-news/2025/07/07/russian-minister-found-dead-after-being-sacked-by-putin/ Trump U-turns on sending weapons to Ukraine (The Telegraph):https://www.telegraph.co.uk/world-news/2025/07/08/donald-trump-us-sends-weapons-ukraine/Russian airlines face $254 million losses from just 2 days of Ukrainian drone strikes, Kremlin media reports (Kyiv Independent):https://kyivindependent.com/drone-disruptions-reportedly-cost-russian-airlines-254-million-exposing-economic-pressure-from-ukraines-campaign-06-2025/ SIGN UP TO THE NEW ‘UKRAINE: THE LATEST' WEEKLY NEWSLETTER:https://secure.telegraph.co.uk/customer/secure/newsletter/ukraine/ Each week, Dom Nicholls and Francis Dearnley answer your questions, provide recommended reading, and give exclusive analysis and behind-the-scenes insights – plus maps of the frontlines and diagrams of weapons to complement our daily reporting. It's free for everyone, including non-subscribers.NOW AVAILABLE IN NEW LANGUAGES:The Telegraph has launched translated versions of Ukraine: The Latest in Ukrainian and Russian, making its reporting accessible to audiences on both sides of the battle lines and across the wider region, including Central Asia and the Caucasus. Just search Україна: Останні Новини (Ukr) and Украина: Последние Новости (Ru) on your on your preferred podcast app to find them. Listen here: https://linktr.ee/ukrainethelatestSubscribe: telegraph.co.uk/ukrainethelatestEmail: ukrainepod@telegraph.co.uk Hosted on Acast. See acast.com/privacy for more information.

This week David and Marina of FAME Architecture & Design are joined by Ana Maria Duran Calisto, Co-Principal of Estudio A0 and Daniel Rose Visiting Assistant Professor at the Yale School of Architecture. The three discussed the shift in relationship between technology, culture and nature in architecture; the cultural background of South America; architecture and the Amazonia; the colonial and monocultural mindset; Ana's educational background; shifting career paths; the University of Amazonia design competition; and more. This episode is supported by Autodesk Forma & Autodesk Insight • Programa • Learn more about BQE CORE SUBSCRIBE  • Apple Podcasts  • YouTube  • Spotify CONNECT  • Website: www.secondstudiopod.com • Office  • Instagram • Facebook  • Call or text questions to 213-222-6950 SUPPORT Leave a review  EPISODE CATEGORIES  •  Interviews: Interviews with industry leaders.  •  Project Companion: Informative talks for clients.    •  Fellow Designer: Tips for designers.  •  After Hours: Casual conversations about everyday life. •  Design Reviews: Reviews of creative projects and buildings. The views, opinions, or beliefs expressed by Sponsee or Sponsee's guests on the Sponsored Podcast Episodes do not reflect the view, opinions, or beliefs of Sponsor.David Lee and Marina Bourderonnet

CHRIS BAUER has appeared in over 300 episodes of television, 40 feature films, and several theater productions on Broadway and Off. His multiple  long running television credits  include Frank Sobotka in ‘THE WIRE', Andy Bellefleur in ‘TRUE BLOOD', and Bobby Dwyer in ‘THE DEUCE' for HBO. Most recently he starred as pro wrestler Wild Bill Hancock on ‘HEELS' for Starz, where he also appeared in ‘GASLIT' with Julia Roberts and Sean Penn, and ‘SURVIVORS REMORSE', produced by LeBron James, and played Joe McCarthy in the Peabody Award winning ‘FELLOW TRAVELERS' for Showtime. On Apple TV Plus, he played Deke Slayton in the inaugural season of ‘FOR ALL MANKIND', and appeared as  Det. Tom Lange in ‘PEOPLE VS OJ' for FX. Recent feature credits include co-starring with Denzel Washington in the Warner Brothers film ‘THE LITTLE THINGS', ‘MONEY MONSTER', and ‘SULLY'. He received an Outer Critic's nomination for playing Mitch in ‘STREETCAR NAMED DESIRE' on Broadway, and has originated roles in plays by David Mamet, Jez Butterworth, and John Patrick Shanley throughout a long career in theater. Upcoming credits include the limited series' 'Unspeakeable' for Paramount Plus, and 'His/Hers' for Netflix. On film he will be seen in 'Henry Johnson' and 'Our Hero Balthazar', as well as '3 Holes and a Donut', a feature film he wrote and directed. Chris is a native of Los Angeles, a  graduate of the Yale School of Drama, and a metalhead. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Welcome to the Sustainable Clinical Medicine Podcast! In this episode, Dr. Sarah Smith sits down with Dr. Jessi Gold, psychiatrist, author, and Chief Wellness Officer for the University of Tennessee system. Together, they delve into Dr. Gold's fascinating journey through medicine—from her early days resisting the pull of psychiatry, despite her father's influence, to finding her true calling in supporting healthcare workers and college students through mental health challenges. Dr. Gold shares candid stories about her own mental health struggles, the barriers to seeking help in medicine, and how the COVID-19 pandemic reshaped her clinical focus to frontline healthcare workers. She opens up about recognizing burnout in herself, the subtlety of its symptoms, and the lessons she learned about self-care, connection, and setting boundaries. Along the way, Dr. Gold offers practical strategies for identifying burnout early, building resilience, and creating sustainable ways to care for ourselves and each other in healthcare. If you've ever wondered how to stay well while caring for others—or found yourself feeling isolated in your own struggles—this episode is for you. Join us as Dr. Gold brings wisdom, vulnerability, and humor to the vital conversation about humanity in medicine, and learn simple, actionable steps you can take to support your own mental health. Let's dive in! Here are 3 key takeaways from this episode: Burnout Creeps in Subtly: It's rarely one big event. The signs can include relentless fatigue, irritability with routine work tasks (like inbox overload!), and gradual withdrawal from friends and family. Often, they go unnoticed until things become critical. Check in With Yourself—Intentionally: Gold emphasizes the importance of pausing after tough clinical interactions to genuinely ask yourself, “How am I doing?” This simple self-awareness practice is more powerful than it sounds and is a foundational skill in building emotional resilience. Connection is Medicine, Too: Vulnerability among colleagues and strong social connections are not just “nice to have”—they're protective against burnout. Sharing how you're really doing creates a culture of support and reduces feelings of isolation in tough times. Meet Dr. Jessi Gold: Jessi Gold, MD, MS is the Chief Wellness Officer of the University of Tennessee System and an Associate Professor in the Department of Psychiatry at the University of Tennessee Health Science Center. This inaugural leadership position encompasses all five University of Tennessee campuses, UT Knoxville, UT Chattanooga, UT Southern, UT Martin, and UT Health Science Center, and includes over 62,200 students and 19,0000 faculty and staff. In her clinical practice, she sees healthcare workers, trainees, and young adults in college. Dr. Gold is also a fierce mental health advocate and highly sought-after expert in the media on everything from burnout to celebrity self-disclosure. She has written widely for the popular press, including for The New York Times, The Atlantic, InStyle, Slate, and Self. Her first book, HOW DO YOU FEEL? One Doctor's Search for Humanity in Medicine came out in October 2024 from Simon Element and is a national bestseller. Dr. Gold is a graduate of the University of Pennsylvania with a B.A. and M.S in Anthropology, the Yale School of Medicine, and Stanford University Department of Psychiatry, where she served as Chief Resident. You can find her book at https://www.simonandschuster.com/books/How-Do-You-Feel/Jessi-Gold/9781982199777 -------------- Would you like to view a transcript of this episode? Click here **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

Are we addicted… to revenge? Neil deGrasse Tyson, Chuck Nice, and Gary O'Reilly break down the neuroscience behind revenge-seeking, what motivates violence, and how science can help stop it with James Kimmel Jr., lawyer, psychiatry lecturer at Yale School of Medicine, and author of “The Science of Revenge.” NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/the-science-of-revenge-with-james-kimmel-jr/Thanks to our Patrons Daniel D., Wendi Su, Jim, Patrick Johnson, Lyleblakeo, Anabel del Val, Alex P, Harry Peters jr, Scott Syme, Katie Littman, Jarrett Rice, James, Mindy Graulich, Bart, John Dragicevich, Michelle Gerez, Renee A Chen, Sarthak Misra, Drew and Bobbi Monks, Nina Kattwinkel, Emir Tenic, Tyler Kunkel, Matt Baldwin, jscribble, Tore Aslaksen, Melina Morgan, kenneth cooke, Dale Ireen Goldstein, Christopher Arnold, Etienne moolman, Daniel S. Hall, Quillan, Jeff Whitacre, Jeremy Schmidt, Brian Reed, Frank, Micheal Trager, Irene, Robert Tillinghast, HeWhoQueries, Samantha, Laura knight lucas, Amagerikaner, Webb Peterson, Jeramiah Keele, Joe Quintanilla, kent simon, Tim Albertson, Fallon Cohen, John Terranova, Phinphan77, yocheved Devehcoy, Lasha Kanchaveli, and Nalini Martin for supporting us this week. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early.Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.

In this episode, I'm joined by James Kimmel Jr. JD, a lecturer in psychiatry at the Yale School of Medicine and author of The Science of Revenge, to explore what the latest neuroscience tells us about revenge, grievance, and retaliation. We discuss how the brain's reward system becomes activated in response to perceived harm—often fueling cycles of conflict that begin in childhood. Together, we examine how understanding these mechanisms can help us teach our children to reframe grievances, regulate emotional responses, and move toward forgiveness, both in everyday sibling conflicts and larger social dynamics.I WROTE MY FIRST BOOK! Order your copy of The Five Principles of Parenting: Your Essential Guide to Raising Good Humans Here: https://bit.ly/3rMLMsLSubscribe to my free newsletter for parenting tips delivered straight to your inbox: draliza.substack.com Follow me on Instagram for more:@raisinggoodhumanspodcast Sponsors:Rylee & Cru: Visit ryleeandcru.com/raisinggoodhumans and use code HUMANS for 20% off your first orderBobbie: Bobbie is offering an additional 10% off on your purchase with the code:humans. Visit www.hibobbie.com to find the Bobbie formula that fits your journey.Venmo: Visit Venmo.me/debit to learn more and sign up todayWayfair: Head to Wayfair.com right now to shop a huge outdoor selectionWater Wipes: Visit WaterWipes.com to learn more about how Water Wipes effectively cleans with minimal ingredients that leave nothing behindBetterHelp: Our listeners get 10% off their first month at BetterHelp.com/HUMANSPhiladelphia Cream Cheese: Visit creamcheese.comPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.S. is the former Director of the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health, and the National Toxicology Program (NTP). After retirement, she was granted scientist emeritus status and still maintains a laboratory. As a board-certified toxicologist, Birnbaum served as a federal scientist for 40 years. Prior to her appointment as NIEHS and NTP Director in 2009, she spent 19 years at the U.S. Environmental Protection Agency (EPA), where she directed the largest division focusing on environmental health research. Birnbaum has received many awards and recognitions. In 2016, she was awarded the North Carolina Award in Science. She was elected to the Institute of Medicine of the National Academies, one of the highest honors in the fields of medicine and health. She was also elected to the Collegium Ramazzini, an independent, international academy comprised of internationally renowned experts in the fields of occupational and environmental health and received an honorary Doctor of Science from the University of Rochester and a Distinguished Alumna Award from the University of Illinois. She has also received Honorary Doctorates from the University of Rhode Island, Ben-Gurion University, Israel, and Amity University, India; the Surgeon General's Medallion 2014; and 14 Scientific and Technological Achievement Awards, which reflect the recommendations of EPA's external Science Advisory Board, for specific publications. Dr. Birnbaum recently received the Winslow Award, the highest honor from the Yale School of Public Health and was elected an AAAS Fellow. She has also received numerous awards from professional societies and citizen's groups. Birnbaum is an active member of the scientific community. She was vice president of the International Union of Toxicology, the umbrella organization for toxicology societies in more than 50 countries, and former president of the Society of Toxicology, the largest professional organization of toxicologists in the world. She is the author of more than 1000 peer-reviewed publications, book chapters, abstracts, and reports. Birnbaum's own research focuses on the pharmacokinetic behavior of environmental chemicals, mechanisms of action of toxicants including endocrine disruption, and linking of real-world exposures to health effects. She is an adjunct professor at the University of Queensland in Australia, the School of Public Health of Yale University, the Gillings School of Global Public Health, the Curriculum in Toxicology, and the Department of Environmental Sciences and Engineering at the University of North Carolina at Chapel Hill, as well as in the Integrated Toxicology and Environmental Health Program at Duke University where she is also a Scholar in Residence. A native of New Jersey, Birnbaum received her M.S. and Ph.D. in microbiology from the University of Illinois at Urbana-Champaign.

You are not your business, but you do owe it your leadership. In this episode, I'm joined by powerhouse founder, coach, and podcast host Eleanor Beaton to unpack what it really takes to build an enduring brand. From mastering premium positioning to separating your personal identity from your product, Eleanor drops truth bombs every product-based founder needs to hear. What You'll Learn: Why being obsessed with your customer is your most underutilized advantage The mindset shift every founder must make to scale sustainably Why women entrepreneurs over-rely on marketing and how to fix it with sales The real difference between producers and replicators (and why it matters for growth) What Fenty and Good American get right about brand positioning If you've ever felt like you're too close to your business to sell it, or you're relying on marketing when it's a sales problem, this conversation is your wake-up call. About Eleanor Eleanor Beaton is the founder of Safi Media, a coaching and education company dedicated to doubling the number of women founders who sustainably scale to $1M+ by 2030, and the host of the Woman Owned podcast, now ranked in the top 0.5% of all podcasts globally, providing insights and strategies to empower women entrepreneurs. Since 2016, Eleanor has provided training to over 25,000 women entrepreneurs worldwide. A former chair of the Visiting Women's Executive Exchange Program at the Yale School of Management, Eleanor has won national awards for her achievements in entrepreneurship, leadership development and business journalism. She lives in Nova Scotia with her husband and two sons. Connect with Eleanor https://www.safimedia.co  https://instagram.com/eleanorbeaton  https://www.linkedin.com/in/eleanorbeaton/  https://safimedia.co/podcast/  ✨ GROW YOUR BRAND: Ready to build an obsession brand and scale it with scientific precision? Connect With Me ✨ FREE TRAINING: Want to identify the One Growth Strategy You Need to Focus on First to Increase Sales Now? Watch the most recent training: Uncap Your Growth & Bring in More Product Sales without Changing Your Branding or Packaging ✨ CONNECT:

In his new book, The Science of Revenge, James Kimmel Jr. argues that there is a human desire to get even – and it might even be an addiction. Kimmel Jr., a professor at the Yale School of Medicine, realized his own taste for retaliation as a teenager and later felt that he would benefit from a kind of "revenge rehab." In today's episode, the author tells NPR's Michel Martin that revenge lights up the same area of the brain activated by drug addiction. They also discuss the role of revenge in U.S. politics and the biological benefits of forgiveness.To listen to Book of the Day sponsor-free and support NPR's book coverage, sign up for Book of the Day+ at plus.npr.org/bookofthedayLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Host: Brian P. McDonough, MD, FAAFP Guest: Hugh S. Taylor, MD Endometriosis care is often delayed due to diagnostic and treatment access challenges—but early recognition and proactive strategies can change that. In this expert-led discussion, Dr. Brian McDonough sits down with Dr. Hugh Taylor to explore how we can clinically diagnose endometriosis without relying on surgery, streamline prior authorizations, and guide patients toward affordable treatment options while empowering patients through advocacy and education. Dr. Taylor is the Anita O'Keeffe Young Professor and Chair of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine.

I was happy to connect with Dr. Louann Brizendine today! She is the founder of the Women's Mood and Hormone Clinic at UCSF. She completed her degree in Neurobiology at the University of California, Berkeley, graduated from Yale School of Medicine, and completed her internship and residency at Harvard Medical School. She also served on the faculty of Harvard University and the University of California, San Francisco. Dr. Brizendine founded the Women's Mood and Hormone Clinic at UCSF. Her New York Times bestseller, The Female Brain, and its follow-up, The Male Brain, continue to be read worldwide.  Today, we dive deeply into her new book, The Upgrade: How the Female Brain Gets Stronger and Better in Midlife and Beyond, which was released in April 2022. IN THIS EPISODE YOU WILL LEARN: The transition and the upgrade stage of life explained Celebrating the transitional time of life and not fearing it How hormones help guide behavior Transition Stages 1,2,3 and what they mean Then onward to the 3 stages of "The Upgrade" Estrogen fluctuations that affect sleep Be aware of caffeine in your food and drinks and how it may affect your sleep. If you are having a problem staying asleep, you may want to cut back on alcohol or drink it earlier in the day. The Women's Health Initiative - (almost 20 years ago) disastrous misinterpretations and negative implications it caused by instilling fear in women to not use Estrogen - including osteoporosis, brain fog, anxiety, and sleep disruptions Hormone Replacement Therapy - now viewed as a positive and much-needed step in women's health Women between the ages of 40-50 should get a bone density scan as one of the determining factors of whether or not to begin hormone replacement therapy. Dr. Brizendine suggests that women should not be fearful of using therapies today to help balance hormones. Cynthia discusses the loss of cognition later in life as another correlative symptom of not receiving needed hormones. Dr. Brizendine advocates doing your own research regarding HRT and not depending only on information from major pharmaceutical companies. Cynthia and Dr. Brizendine discuss the importance of keeping an open mind when it comes to synthetic hormones because of the good they can do. If you are not well and do not feel like you can go on, please, immediately, seek out a doctor who can prescribe medications or hormones to help your particular and unique situation. Be your best and do not suffer in silence any longer. Cynthia says the transitional time of life should and can be a very good time in your life. Consider reading Dr. Brizendine's book(s) to learn more and to keep it as a valuable resource.  Connect with Cynthia Thurlow Follow on X, ⁠Instagram⁠ & ⁠LinkedIn⁠ Check out Cynthia's ⁠website⁠  Connect with Dr. Brizendine ⁠Website⁠ ⁠Facebook⁠ ⁠Instagram⁠ ⁠LinkedIn⁠ ⁠TikTok⁠ Dr. Louann Brizendine's Books ⁠The Upgrade⁠ (newest book) ⁠The Female Brain⁠ ⁠The Male Brain⁠ Resource Mentioned ⁠NAMS - North American Menopause Website

Send us a textGreat conversation with the one and only Dr. Katelyn Jetelina, AKA Your Local Epidemiologist, about the power of showing up, the experience with members of the Make America Healthy Again movement on the Why Should I Trust You podcast, the work of distinguishing public health from the industrial complexes of food and pharma and insurance and also acknowledging that the status quo of public health needs to change and taking that first step no matter how small because it matters.  Such a rich conversation and we were so honored to have her!Dr. Katelyn Jetelina is an epidemiologist and scientific communicator. She is the co-founder of the non-profit Health Trust Initiative, an adjunct professor at Yale School of Public Health, and former Senior Scientific Advisor to the White House and Centers for Disease Control and Prevention. In addition, Dr. Jetelina is the publisher of Your Local Epidemiologist- a public health newsletter that “translates” ever-evolving science to the public, reaching over 500 million views in over 133 countries. Dr. Jetelina has received numerous national awards, including recently being named a TIME100 Most Influential Person in Health. Check out her newsletter https://yourlocalepidemiologist.substack.com/p/what-would-making-america-healthyCheck out our YouTube Channel https://www.youtube.com/@helpmakeitmakesense6769/aboutSend us your questions and comments to drtonianddraimee@gmail.comThanks to Jeff Jeudy for our themesong!

  Today, on Notable Leaders' Radio, I speak with Amy Chinian, Founder & Visionary Behind My Hair Helpers She highlights how perseverance, creativity, and unwavering faith helped her overcome financial hardship and build a successful lice removal business from the ground up. In today's episode, we discuss: Perseverance, creativity, and unwavering faith can turn even the toughest setbacks into a thriving business and renewed purpose,  showing that consistent effort and a solutions-oriented mindset often transform adversity into a life-changing opportunity. Aligning your work with a mission to help others leads to deeper fulfillment and genuine impact, demonstrating that purpose-driven actions not only benefit others but also bring meaning to your everyday life. Choosing faith over fear transforms anxiety into clear decision-making and emboldens you to bravely move forward even when the outcome isn't guaranteed. Using your gifts to uplift others creates meaning that transcends financial or external success, proving that your greatest legacy comes from the positive difference you make in the lives of those around you.   RESOURCES:   Guest Bio: Amy Chinian is the founder of My Hair Helpers, a head lice removal company rooted in compassion, education, and empowerment. After experiencing a significant financial setback, Amy rebuilt her life and business from the ground up, turning a deeply personal challenge into a thriving nationwide brand. With a focus on non-toxic solutions, expert-level service, and unmatched customer care, Amy has become a trusted voice for families navigating difficult situations.    Her journey is a testament to perseverance, faith, and the power of purpose-driven entrepreneurship.   Website/Social Links: info@myhairhelpers.com  Website: www.myhairhelpers.com   Instagram: www.instagram.com/myhairhelpers   YouTube: https://www.youtube.com/channel/UCixbWLmr50f9frZZPQYv15w   LinkedIn: https://www.linkedin.com/in/amy-chinian-90697b22/   Belinda's Bio: Belinda Pruyne is a renowned Leadership Advisor, Executive Coach, Consultant, and Keynote Speaker recognized for her ability to transform executives, professionals, and small business owners into highly respected, influential leaders. As the Founder of BelindaPruyne.com, she partners with top-tier organizations, including IBM, Booz Allen Hamilton, BBDO, Hilton, Leidos, Yale School of Medicine, Landis, Discovery Channel, and the Portland Trail Blazers. Recently, she led the redesign of two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is also a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. A thought leader in leadership development, Belinda is the creator and host of the Notable Leaders Radio podcast, where she has conducted 95+ interviews with top executives and business leaders, revealing the untold stories behind their success. Previously, as Executive Vice President, Global Director of Creative Management at Grey Advertising, she oversaw a global team of 500 professionals, gaining deep expertise in client services and executive leadership. With 25+ years of experience, Belinda is a trusted advisor to startups, turnarounds, acquisitions, and Fortune 500 companies, delivering strategic, high-impact solutions in today's fast-evolving business landscape.   Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

In this episode of Medical Ethics Unpacked, hosts Dominic Sisti and Steve Levine welcome Jason Schwartz, PhD, associate professor at the Yale School of Public Health, for a discussion on vaccine ethics, public health infrastructure, and the challenges of maintaining trust in immunization programs. Together, they explore how the COVID-19 pandemic reshaped public attitudes toward vaccines, while also underscoring long-standing tensions between individual autonomy and collective responsibility. Schwartz, whose work focuses on vaccine policy and history, offers perspective on the systems and institutions, such as the CDC's Advisory Committee on Immunization Practices (ACIP), helping to translate scientific evidence into public health recommendations. This episode comes at a time when ACIP is once again in the headlines as HHS Secretary Robert F. Kennedy Jr. recently replaced all 17 members with a new slate of individuals, citing concerns about groupthink and conflicts of interest. The move has generated widespread commentary about the role and value of such expert advisory bodies in shaping public health decisions, especially in the face of growing skepticism and political scrutiny. Ethical questions about equity, communication, and responsibility are threaded throughout the discussion. The hosts and Schwartz reflect on what it means to make fair vaccine recommendations in the context of incomplete data, and how institutions can maintain public trust amid scientific uncertainty. They also discuss how the infrastructure behind public health decisions—committees, advisory boards, and interagency coordination—can either strengthen or undermine confidence depending on how they function and how well they are understood. Chapters 00:00 – Introduction and Vaccine Policy in Crisis 03:00 – The Long History and New Politics of Vaccine Skepticism 09:30 – Erosion of Public Health Infrastructure and Expert Advisory Systems 14:50 – Why Vaccines Became a Political Flashpoint 19:10 – Clinician Ethics and the Vaccine-Hesitant Patient 32:00 – Data, Misinformation, and the Future of Vaccine Trust References: Stone W. RFK Jr. names new slate of vaccine advisers after purging CDC panel. NPR. Published June 11, 2025. Accessed June 17, 2025. https://www.npr.org/sections/shots-health-news/2025/06/11/nx-s1-5430870/cdc-vaccine-experts-rfk-jr Asturias EJ, Brewer NT, Brooks O, et al. Advisory Committee on Immunization Practices at a Crossroads. JAMA. Published online June 16, 2025. doi:10.1001/jama.2025.10776

In this powerful episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with Dr. Preston Sprenkle, leading urologic oncologist at Yale School of Medicine, to explore the emerging role of focal therapy in prostate cancer care. A pioneer in MRI-ultrasound fusion biopsy using the Artemis Device, Dr. Sprenkle shares how focal treatments can offer cancer control while preserving quality of life.Whether you're on active surveillance or facing a Gleason 7 or 8 diagnosis, this episode helps you better understand:When focal therapy is appropriate—and when it's notKey differences between cryoablation, IRE (NanoKnife), and Tulsa Pro How patient goals (erectile function, continence, cancer control) shape treatmentWhat recent research shows about focal therapy success ratesHow to approach higher-risk prostate cancer (Gleason 8–10) with focal therapyWhat to know about PSMA PET scans, genomic tests, and repeat biopsiesThe real risks of skipping follow-up on active surveillanceYou'll also hear candid reflections on the evolution of holistic and integrative urology, and why building trust with your urologist matters more than ever.

Dr. David Kessler is a renowned pediatrician, lawyer, public health advocate, and former Commissioner of the U.S. Food and Drug Administration (FDA). A graduate of Amherst College, the University of Chicago Law School, and Harvard Medical School, Dr. Kessler has spent his career at the intersection of science, policy, and consumer protection. He served as Dean of the Yale School of Medicine and the University of California, San Francisco Medical School, and most recently held the role of Chief Science Officer for the White House COVID-19 Response Team. Dr. Kessler is the acclaimed author of several influential books including the New York Times bestseller The End of Overeating, Fast Carbs, Slow Carbs, and his latest work, Diet, Drugs & Dopamine: The New Science on Achieving a Healthy Weight. His writing and research have been pivotal in shifting the public health conversation from willpower to biological understanding—especially regarding food addiction, the manipulation of hyper-palatable foods, and the role of dopamine in modern eating behaviors. A true trailblazer in the field, Dr. Kessler has dedicated decades to unraveling the powerful science behind why we eat the way we do—and how we can reclaim our health in a world of ultra-processed foods. Dr. Kessler shares his personal journey with weight regain and the "aha moment" that led him to call it what it is—addiction. He explores the role of GLP-1 medications, the dark side of food addiction, and how we must move beyond willpower to tackle this epidemic with compassion, science, and actionable tools.

Today, on Notable Leaders' Radio, I speak with Fairley McCaskill, Media Strategist & Founder | SJ&Y PR. She shares how resilience, self-awareness, and intentionality shaped her journey from single motherhood to becoming a successful leader in the music industry.   In today's episode, we discuss: Reflect on your roots for career inspiration. Look at your childhood passions and the environments you grew up in to uncover talents and interests that could shape your future.  Unlock personal clarity and direction by revisiting what has always inspired you. Make resilience your superpower. Don't shy away from difficulties; instead, view them as chances to adapt, overcome, and thrive.  Experience a mindset shift that empowers you to tackle anything life throws at you. Let go of perfectionism to unlock real progress. Recognize that mistakes and imperfection are part of success, not enemies of it. Reduce stress and open yourself up to greater creativity, innovation, and satisfaction. Use storytelling to connect and build impact. Telling your story authentically can foster deep connections and inspire others.  Discover your purpose and influence by sharing what makes you unique and learning to view your journey as a valuable narrative. Step up to visible leadership, especially if you've been behind the scenes. Don't be afraid to let your work, perspective, and presence be recognized.  Inspire others, open doors for yourself, and shape the spaces you're in.   RESOURCES:   Guest Bio Fairley McCaskill is a leading media strategist known for shaping culturally resonant narratives and elevating bold, authentic voices. Her recent client roster reflects both legacy and next-gen talent — including Missy Elliott, Jason Derulo, Janelle Monáe, BRELAND, Flyana Boss, Alicia Creti, and Raiche among others — and she brings both sharp strategy and a deeply human touch to every campaign. Whether amplifying icons or launching rising stars, Fairley blends industry insight with creative direction to build lasting visibility and purpose-driven impact. She's a trusted voice behind the scenes, aligning artists, personalities, and brands with the moments, messages, and platforms that matter most. With a passion for powerful storytelling and purpose-led branding, Fairley has built a reputation for representing talent and projects that stand for something — across music, film, fashion, and advocacy. Her work lives at the intersection of visibility and integrity, where media strategy, talent relations, and cultural insight come together to create long-term narratives that resonate. To Fairley, good PR is more than just press — it's about presence, purpose, and transformation. She is the steady, strategic hand helping talent show up in the world as their most aligned and amplified selves.  “I create uncommon connections that produce uncommon results.”  ~Fairley McCaskill    Website/Social Links IG: @susiejuan  LinkedIn: https://www.linkedin.com/in/fairleymccaskill   Belinda's Bio: Belinda Pruyne is a renowned Leadership Advisor, Executive Coach, Consultant, and Keynote Speaker recognized for her ability to transform executives, professionals, and small business owners into highly respected, influential leaders. As the Founder of BelindaPruyne.com, she partners with top-tier organizations, including IBM, Booz Allen Hamilton, BBDO, Hilton, Leidos, Yale School of Medicine, Landis, Discovery Channel, and the Portland Trail Blazers. Recently, she led the redesign of two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is also a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. A thought leader in leadership development, Belinda is the creator and host of the Notable Leaders Radio podcast, where she has conducted 95+ interviews with top executives and business leaders, revealing the untold stories behind their success. Previously, as Executive Vice President, Global Director of Creative Management at Grey Advertising, she oversaw a global team of 500 professionals, gaining deep expertise in client services and executive leadership. With 25+ years of experience, Belinda is a trusted advisor to startups, turnarounds, acquisitions, and Fortune 500 companies, delivering strategic, high-impact solutions in today's fast-evolving business landscape.     Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

The Trombone Corner Podcast is brought to you by Bob Reeves Brass and The Brass Ark.  Join hosts Noah and John as they interview Dr. Brittany Lasch, trombone soloist and professor at Indiana University.   About Brittany: A winner of the S&R Foundation Washington Award and Astral Artists National Auditions, trombonist Brittany Lasch brings authenticity and unshakeable commitment to all aspects of her music-making. Increasingly in demand as a soloist with orchestras and brass bands alike, Brittany balances an intensive performance career with her role as a sought-after educator and newly appointed Assistant Professor of Trombone at the renowned Jacobs School of Music at Indiana University. As a serial collaborator and commissioner of composers, Brittany is a musical explorer creating new repertoire for her instrument from some of today's most compelling voices, and true ambassador in expanding recognition for the trombone as a powerful solo voice for today. Brittany has appeared as a soloist with ensembles ranging from the U.S. Army Band “Pershing's Own”, Rodney Marsalis Philadelphia Big Brass, and for concerto performances with the Queens Symphony, National Repertory Orchestra, Bucks County Symphony, Bowling Green Philharmonia, Manhattan School of Music Philharmonia, and others across the country. With playing described as “masterful” (Syracuse Post-Standard), American Record Guide recently hailed Brittany as an "excellent soloist" across a diverse range of repertoire.  Brittany has been a featured guest artist at numerous festivals, including the International Trombone Festival, the International Women's Brass Conference, and the American Trombone Workshop. She was a winner of the National Collegiate Solo Competition hosted by the U.S. Army Band, the Eisenberg-Fried Brass Concerto Competition at the Manhattan School of Music, the Zulalian Foundation Award in Boston. Her trombone quartet Boston Based won the 2017 International Trombone Association's Quartet Competition. In 2018, Brittany was awarded 2nd place in The American Prize Solo Instrumentalist competition. A prizewinner in numerous other competitions, she received the coveted John Clark Award upon graduation from the Manhattan School of Music for outstanding accomplishment in brass performance. For six seasons, Brittany was the Principal Trombone of the Detroit Opera Orchestra at the Detroit Opera House. She has performed with orchestras nationwide, including the San Francisco Symphony, Los Angeles Philharmonic, Indianapolis Symphony, St. Louis Symphony, Detroit Symphony, Nashville Symphony, The Florida Orchestra, Toledo Symphony Orchestra, ProMusica Chamber Orchestra, Rhode Island Philharmonic, the Oregon Bach Festival Orchestra, the Vermont Symphony, Albany Symphony, Syracuse Symphony, and the New World Symphony in Miami Beach. She participated in the Verbier Festival Orchestra for two summers, and has also appeared at the Spoleto USA Festival, the Pacific Music Festival in Sapporo, Japan, the Castleton Festival, and the Aspen Music Festival. An active presence in the global trombone community, Brittany's performances for the current and past seasons include Argentina's Trombonanza, Portugal's Gravíssimo Festival, as well as appearances in Japan and Korea. As an advocate for new music, Brittany has commissioned and performed several new pieces for the trombone, including acclaimed composer Reena Esmail's major Sonata for Trombone and Piano, which she commissioned for her Astral Artists recital in Philadelphia. Brittany gave the premiere of the orchestrated version of Martin Kennedy's Theme and Variations for Trombone and Orchestra with the BGSU Philharmonia under the direction of Dr. Emily Brown. She also recorded the work with the BGSU Philharmonia, which was recently released on the Albany Records label. Other recent projects include collaborations with composers Inez McComas, Adam Har-zvi, and David Miller. Her debut solo album Dark Horse features works by Samuel Adler, Tony Plog, Reena Esmail, Shawn Davern, and the album's pianist, Thomas Weaver. A native of Park Ridge, Illinois, Brittany earned her Doctor of Musical Arts degree from Boston University, where she received the Brass Department Award. She also holds a Master of Music degree from Yale School of Music. With a deep commitment to education, she has previously served as faculty at the College of Musical Arts at Bowling Green State University and the Boston University Tanglewood Institute. She has also been a featured teacher and performer at summer festivals, including the Sewanee Music Festival and the DC Trombone Workshop. Recent residencies include those at the University of Central Arkansas, James Madison University (Tromblow'in), University of Iowa, Oklahoma State University, Stetson University, the University of Florida, and as the guest artist at the 2023 Frühling Posaunen hosted at Ithaca College. She has presented masterclasses at universities across the country and internationally. Brittany Lasch is an Edwards Trombone Performing Artist. She also proudly uses and endorses ChopSaver Lip Care. Outside of music, Brittany has recently completed her eleventh full marathon and loves spending time with her cats, Clove and Poppyseed.

Amanda Kallen is an associate professor in the Division of Reproductive Endocrinology and Infertility at the University of Vermont Larner College of Medicine and an adjunct professor at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.N. Kallen and Others. Undermining Women's Health Research — Gambling with the Public's Health. N Engl J Med 2025;392:2185-2187.

In this season finale, we do something a little different. Instead of featuring an outside guest, we bring you behind the scenes—with the voices and minds who help design and deliver the very work this podcast explores. Dr. Heidi Brooks is joined by her colleagues David Tate and Stacey Casamassima for a candid, deeply human conversation that essentially doubles as a real team meeting. This is the team that teaches and leads “Everyday Leadership” at Yale and facilitates high-touch programs like Interpersonal and Group Dynamics, Holding Space, and more. And this time, they're turning the mic inward. Together, they reflect on the life experiences that drew them to this work, the evolution of their own learning journeys, and the frameworks and practices they use to create conditions for meaningful growth—within themselves, their students and each other. They discuss what it means to “stay” in difficult moments, how trust and ambiguity support learning, and why the ability to be present—with curiosity and care—is at the heart of human development. If you've ever wondered how transformational learning environments are built, or who's behind the scenes making them possible, this conversation is for you. Listen in as we lift the veil, share the practice, and reflect on what it really takes to co-create the conditions for learning—with integrity, intention and hope. Learning Through Experience is produced through the Yale School of Management. What resonates with you about this conversation? We'd love to hear from you—reach out to LTEpodcast@yale.edu. And subscribe to the monthly LinkedIn newsletter for additional insights and reflections about episode topics and questions to ponder.  Watch this episode on YouTube. Show Notes & Key Moments 00:06 – Opening the Circle: Why This Episode, Why This TeamDr. Heidi Brooks frames the episode as a rare look behind the scenes of the work and the people who create the conditions for learning. 03:02 – Disillusionment, Discovery and Stacey's Path to the Work"My graduate degree rescued me from the cynicism I found in the working world... It shaped fundamentally how I move through the world." 06:50 – The Early Seeds of David's WorkDavid Tate traces his call to group work back to junior high: "I wasn't doing much—just listening. But that act of holding space was more powerful than I realized." 16:46 – Doing Nothing—or Everything? Heidi's Story of Early Impact"They asked me to stop bringing research and just ask questions. I thought I was doing nothing—but something powerful was happening in that space." 28:06 – What Creates the Conditions for Learning?Stacey and David explore the inner and outer structures that make learning possible—from psychological safety to intentional ambiguity and trust. 40:19 – Against Individualism: Learning as a Shared, Social Experience"Can we meditate out loud—together?" Stacey reframes learning as a relational practice that counters dominant culture's emphasis on the individual. 46:32 – Stay or Cancel? Trust, Reaction, and the Practice of Presence"Stay is not the same as tolerate." The team discusses cancel culture, self-protection, and the challenge of staying present through discomfort and difference. 53:10 – The Power of Discussability and Repair"Not only are we noticing, but we're going to talk about it—and recover." Stacey reflects on what makes it possible to risk and trust in community. 57:01 – Hope for Humanity: What This Work Makes Possible"Our students go out and ripple this work into the world. That gives me hope." David and Stacey share final reflections on why this work matters. Resources: Yale Courses in Organizational Behavior: https://faculty.som.yale.edu/heidibrooks/courses/ David C. Tate: https://som.yale.edu/faculty-research/faculty-directory/david-c-tate

Revenge isn't just an emotional impulse—it's an addiction. Dr. Phil and James Kimmel, Jr., JD, break down its impact on the brain and how forgiveness rewires our chemistry for healing. Revenge feels like justice, but what if it's more like an addiction? Dr. Phil and James dive into the neuroscience behind revenge—how it hijacks our brain's pain and reward systems just like substance dependency. They explore how society reinforces these cycles, why letting go isn't weakness, and how forgiveness actually rewires the mind. Plus, Kimmel's “Non-Justice System” offers a fresh way to process grudges without fueling destruction. In Kimmel's latest groundbreaking book, The Science of Revenge: Understanding the World's Deadliest Addiction and How to Overcome It, unveils the unseen neurobiological forces behind our compulsive desires for retribution—an addiction that silently fuels violence and aggression in all its forms. James Kimmel, Jr., JD, is a lecturer in psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. A breakthrough scholar and expert on revenge, he first identified compulsive revenge seeking as an addiction and developed the behavioral addiction model of revenge as a public health approach for preventing and treating violence. He is the creator of The Nonjustice System https://nonjustice.org/ , the Miracle Court app https://www.miraclecourt.com/and https://SavingCain.org  for recovering from grievances and revenge desires and preventing mass violence. He maintains an active legal practice and speaking calendar and is the author of two other books on revenge: Suing for Peace: A Guide for Resolving Life's Conflicts and The Trial of Fallen Angels, a novel. Special thanks to our sponsors! Support the brands that support us! Visit them and let them know we sent you: Jase Medical: Get emergency antibiotics at https://Jase.com/  & use code PHIL for a discount. Kikoff: Build credit fast and get your first month for just a dollar at https://GetKikoff.com/phil/ today. Thanks to Kikoff for sponsoring us! Echo Water: Find your flow state. Visit https://echowater.com/PHIL/ & Use code PHIL for 10% off. MASA Chips: Visit: https://MASAChips.com/MERIT/ and use code MERIT for 25% off your first order. Balance of Nature: Go to https://balanceofnature.com/  or call 1.800.246.8751 and get this special offer by using Discount Code: “DRPHIL”. Get a FREE Fiber & Spice supplement, plus 35% OFF your first preferred set as a new Preferred Customer, with free shipping and our money-back guarantee. Start your journey with Balance of Nature.   Preserve Gold: Visit: https://drphilgold.com/ Get a FREE precious metals guide that contains essential information on how to help protect your accounts. Text “DRPHIL” to 50505 to claim this exclusive offer from Preserve Gold today.

LifeBlood: We talked about the science of revenge, what it is and why it's so attractive, James' harrowing backstory that led him to this work, how and why forgiveness is the key to avoiding and or stopping this addiction from taking hold, and who this desire will ultimately destroy, with Dr. James Kimmel, Jr., JD, a lecturer in psychiatry at the Yale School of Medicine, and author.  Listen to learn how to effectively let go of our desire for revenge and retribution! You can learn more about James at JamesKimmelJr.com, X, and Linkedin. Get your copy of The Science of Revenge here: https://amzn.to/3DwIaSf  Thanks, as always for listening! If you got some value and enjoyed the show, please leave us a review here: ​​https://ratethispodcast.com/lifebloodpodcast You can learn more about us at LifeBlood.Live, Twitter, LinkedIn, Instagram, YouTube and Facebook or you'd like to be a guest on the show, contact us at contact@LifeBlood.Live.  Stay up to date by getting our monthly updates. Want to say “Thanks!” You can buy us a cup of coffee. https://www.buymeacoffee.com/lifeblood Copyright LifeBlood 2025.

Is it healthier to be short or tall? Not that you can do much about it – but this episode begins by exploring some interesting health differences between the tall and the short. https://www.bbc.com/news/health-32117018 All of us have had the urge to get revenge on someone for something they did to us. Seeking revenge is a very powerful feeling that many people cannot control. Yet, more often than not, getting revenge is not that satisfying and you often end up regretting it - road rage being the perfect example. James Kimmel, Jr. joins me to help us understand why feelings of revenge are hard to tame and what you can do when you feel revenge to de-escalate the situation. James is a lecturer in psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is author of a book called The Science of Revenge: Understanding the World's Deadliest Addiction--and How to Overcome It (https://amzn.to/3SPx8v2). Fear of snakes is very common. Lots of people hate them - but the fact is they are fascinating creatures which have adapted to survive everywhere on earth (except one place). There are snakes that lay eggs and snakes who have live births. There are snakes that eat every day and snakes that eat only once a year. And just how dangerous are they? That depends. Listen as I talk with Stephen S. Hall, a science writer whose work has appeared in the New York Times Magazine, The Atlantic Monthly, National Geographic, Wired, Science, and more. He is author of the book Slither: How Nature's Most Maligned Creatures Illuminate Our World (https://amzn.to/44OPyne). People like to put their best foot forward on social media and often they will brag about a promotion or romance or post a photo of their new car or boat. But how is that actually received by the people who see it? Listen as I reveal what people think about this sort of “humble bragging.” https://www.sciencedaily.com/releases/2015/05/150512104037.htm PLEASE SUPPORT OUR SPONSORS!!! MINT MOBILE: Ditch overpriced wireless and get 3 months of premium wireless service from Mint Mobile for 15 bucks a month at ⁠⁠⁠⁠⁠⁠https://MintMobile.com/something⁠⁠⁠⁠⁠⁠ ! FACTOR: Eat smart with Factor! Get 50% off at ⁠⁠⁠⁠⁠⁠⁠⁠https://FactorMeals.com/something50off⁠⁠⁠⁠⁠⁠⁠⁠ TIMELINE: Get 10% off your order of Mitopure!  Go to ⁠⁠⁠⁠⁠⁠⁠⁠https://Timeline.com/SOMETHING⁠⁠⁠⁠⁠⁠⁠⁠ ROCKET MONEY: Cancel your unwanted subscriptions and reach your financial goals faster! Go to ⁠⁠⁠https://RocketMoney.com/SOMETHING⁠⁠⁠ QUINCE: Elevate your shopping with Quince! Go to ⁠⁠⁠⁠⁠⁠⁠⁠https://Quince.com/sysk⁠⁠⁠⁠⁠⁠⁠⁠ for free shipping on your order and 365 day returns! INDEED: Get a $75 sponsored job credit to get your jobs more visibility at ⁠⁠⁠⁠⁠⁠⁠⁠https://Indeed.com/SOMETHING⁠⁠⁠⁠⁠⁠⁠⁠ right now! DELL: The power of Dell AI with Intel inside is transforming the world of pro sports! For the players and the fans who are there for every game. See how Dell Technologies with Intel inside can help find your advantage, and power your wins at ⁠⁠⁠⁠https://Dell.com/Wins⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Revenge sounds like a good idea sometimes. Whether you want to get back at an ex or you want to hurt a coworker who wronged you, there's a reason why you might fantasize about getting even. It has to do with the way your brain works. Today's guest, James Kimmel Jr., is a researcher at Yale School of Medicine and the author of The Science of Revenge. He'll discuss how revenge becomes addictive and why you shouldn't entertain the idea. Some of the things we talk about today are: Why revenge is a natural human craving and how it activates your brain's addiction pathways How to recognize and break free from toxic revenge cycles The surprising science behind forgiveness and why it's better for you than revenge A powerful mental exercise to help you move beyond resentment How letting go of revenge can help you build resilience and mental strength Want more tips for building mental strength? Subscribe to ⁠Mentally Stronger Premium⁠ and get weekly AMA episodes and monthly bonuses to help you grow mentally stronger! Links & Resources JamesKimmelJr.com The Science of Revenge Episode 182 — The Science of Forgiveness Connect with the Show Buy Amy's ⁠⁠books on mental strength⁠⁠ Connect with Amy on Instagram — ⁠⁠@AmyMorinAuthor⁠⁠ ⁠AmyMorinLCSW.com ⁠ Sponsors OneSkin — Get 15% off OneSkin with the code STRONGER at ⁠⁠⁠⁠https://www.oneskin.co/⁠⁠⁠⁠ #oneskinpod Calm — Get 40% off a Calm Premium Subscription at ⁠⁠⁠⁠calm.com/STRONGER⁠⁠⁠⁠ AirDoctor — Head to ⁠⁠⁠⁠AirDoctorPro.com⁠⁠⁠⁠ and use promo code STRONGER to get UP TO $300 off today! Shopify — Sign up for your one-dollar-per-month trial period at ⁠⁠⁠⁠Shopify.com/mentallystronger⁠⁠⁠⁠ ZocDoc - Go to Zocdoc.com/STRONGER to find and instantly book a top-rated doctor today! Mentally Strong — Sign up for your free 7-day trial at MentallyStrong.Downpait.Ai⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Revenge, why do we want to get revenge so bad? And where does that urge come from? And how do we go from wanting to get revenge to being able to forgive someone or others? James Kimmel Jr., Yale lecturer and co-founder of the Yale Collaborative for Motive Studies, is on Getting Better this week to teach us just that. James gives us insight into the psychology of these complex emotions, the parts of the brain affected, and what research, studies and science shows us about forgiveness. James Kimmel, Jr., JD, is a lecturer in psychiatry at the Yale School of Medicine, the founder and co-director of the Yale Collaborative for Motive Control Studies, and a researcher, lawyer, and novelist who focuses on neuroscience, psychology, revenge, addiction, forgiveness, and violence. A breakthrough scholar and expert on revenge and forgiveness, he first identified compulsive revenge seeking as an addiction and first developed the behavioral addiction model of revenge and the brain disease model of revenge addiction as public health approaches for preventing and treating violence. More can be found on his personal website, www.jameskimmeljr.com. Full Video Episodes now available on YouTube. Not A Phase. Trans Lifeline Follow us on Instagram @gettingbetterwithjvn Jonathan on Instagram @jvn Senior Producer, Chris McClure Producer, Editor & Engineer is Nathanael McClure Production support from Julie Carrillo, Anne Currie, and Chad Hall Our theme music is also composed by Nathanael McClure. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today on Mea Culpa, I'm joined by Yale Professor Jeffrey Sonnenfeld, a leading expert on leadership, corporate ethics, and government accountability. He's the Senior Associate Dean at the Yale School of Management, organizer of the CEO Summit, and author of “Firing Back,” where he wrote about Donald Trump. After spending a weekend with him at Yale, I knew I had to bring him on the show. We break down the dangerous mix of spectacle and power behind Trump's second-term agenda, from chaotic trade wars and hollow cabinet picks to the politicization of education and dismantling of oversight. Professor Sonnenfeld offers chilling insights into how Trump's reality-TV ethos is shaping public policy, why authoritarianism feeds on chaos and loyalty, and what business leaders and civil society must do now to defend our democracy. Thanks to our sponsors: Hims: Start your free online visit today at Hims.com/COHEN. Graza: Take your food to the next level with Graza Olive Oil. Visit https://graza.co/COHEN and use promo code COHEN  today for 10% off of TRIO! Wild Alaskan: Go to https://wildalaskan.com/COHEN for $35 OFF your first box of premium, wild-caught seafood. Subscribe to Michael's NEW Youtube Channel: https://www.youtube.com/@TheMichaelCohenShow Join us on Patreon: https://www.patreon.com/PoliticalBeatdown Add the Mea Culpa podcast feed: https://www.meidastouch.com/tag/mea-culpa-with-michael-cohen Add the Political Beatdown podcast feed: https://www.meidastouch.com/tag/political-beatdown Learn more about your ad choices. Visit megaphone.fm/adchoices